Target intelligence / Profile preview

Acquired salivary pellicle (ASP) (ASP)

Target
ASP
Molecular classification
Other
01

Overview

The acquired salivary pellicle (ASP) is a thin, acellular, organic film that forms on the tooth surface immediately after exposure to saliva. It is composed of a complex mixture of salivary proteins, glycoproteins, lipids, and enzymes that selectively adsorb onto the hydroxyapatite of the enamel (Siqueira et al., 2012, J Dent Res). The ASP serves several critical biological functions, including lubricating the oral surfaces to prevent wear, regulating mineral exchange between the tooth and saliva, and acting as a semi-permeable barrier against dietary acids (Hannig & Hannig, 2009, Monogr Oral Sci). However, it also serves as the primary substrate for the initial attachment of oral bacteria, leading to the formation of dental plaque and subsequent diseases such as caries and periodontitis (Lendenmann et al., 2000, Crit Rev Oral Biol Med). Therapeutic strategies targeting the ASP often focus on modifying its composition to enhance its protective properties or to inhibit the adhesion of pathogenic microorganisms (Vacca-Smith & Bowen, 2000, Arch Oral Biol). Drugs such as chlorhexidine and fluoride interact with the pellicle to provide antimicrobial effects or strengthen the enamel-pellicle interface.

Other names
Dental pellicleSalivary pellicleEnamel pellicleAcquired enamel pellicle (AEP)
02

Mechanism of action

Modification of pellicle composition to inhibit bacterial adhesion, enhancement of remineralization, and provision of a physical barrier against acid-induced demineralization.

03

Biological functions

LubricationMineral homeostasisProtective barrierBacterial adhesion substrateOther
04

Disease associations

InfectionOther
05

Safety considerations

Disruption of the natural oral microbiomeExtrinsic tooth stainingPotential loss of protective lubricationAltered taste perception (dysgeusia)
06

Interacting drugs

Chlorhexidine

4 more in the full profile.

07

Biomarkers

Pellicle thicknessStatherin concentrationMUC5B levelsEarly bacterial colonizer count

Beyond the preview

Go deeper on Acquired salivary pellicle (ASP) (ASP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acquired salivary pellicle (ASP) (ASP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call